Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...

The side effects of Dulera and Symbicort are similar. Both of these drugs are combination inhalers. They both contain formoterol, which is a long-acting beta-agonist (LABA) drug. They both also ...

Short-acting albuterol and other beta-agonists should not be used regularly for the control of asthma. People who might benefit from being placed on an inhaled steroid like fluticasone or Pulmicort or ...

Symbicort (budesonide+formoterol) is a combination formulation containing budesonide, an inhaled corticosteroid that treats underlying inflammation, and formoterol, a long-acting beta2-agonist ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

Confounding factors, such as physical activity level and smoking status, can complicate assessment of the contribution of inhaled steroids to declining BMD. In this Swedish study, researchers ...

Do inhaled corticosteroids elevate risk for pneumonia in patients with chronic obstructive pulmonary disease? Several clinical trials, observational studies, and meta-analyses suggest that they do ...

(An active ingredient is what makes a drug work.) Albuterol is a beta 2-agonist bronchodilator, and budesonide is an inhaled steroid. This article describes the dosage of Airsupra, as well as its ...

It was not immediately clear if steroids played a role in his death. Turkish authorities did not immediately respond to a request for comment.

Australian fitness influencer Jaxon Tippet, who built a sizable following with online content focused on exercise and personal motivation while also candidly discussing his past addiction to ...

We've not often seen big discounts on the gorgeously designed Molekule Air Mini+ so this one had us breathing heavily in that newly-purified air. When you purchase through links on our site, we ...